Dimensional Fund Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Dimensional Fund Advisors’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-978	Closed	-$51K	–	3547
2022 Q1	$51K	Hold	978	–	–	﹤0.01%	3463
2021 Q4	$54K	Sell	978 -152	-13%	-$9.7K	﹤0.01%	3487
2021 Q3	$87K	Sell	1,130 -1,737	-61%	-$147K	﹤0.01%	3440
2021 Q2	$372K	Buy	+2,867	New	+$397K	﹤0.01%	3219
2019 Q1	–	Sell	-449	Closed	-$57K	–	3466
2018 Q4	$57K	Hold	449	–	–	﹤0.01%	3397
2018 Q3	$184K	Buy	449 +64	+17%	+$29.6K	﹤0.01%	3319
2018 Q2	$208K	Buy	385 +303	+370%	+$161K	﹤0.01%	3247
2018 Q1	$38K	Buy	+82	New	+$44.7K	﹤0.01%	3322

Other funds holding TCON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Dimensional Fund Advisors's TCON Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2022, closing a stake of 978 shares — an estimated $51K sold.

Dimensional Fund Advisors first reported a position in TCON in Q1 2018 and held it in 8 quarters. The position peaked at $372K in Q2 2021. 31 funds tracked by Wall St. Rank hold TCON as of Q2 2022.

Dimensional Fund Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 978 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $51K.
Dimensional Fund Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 8 quarters.
Dimensional Fund Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $372K in Q2 2021.
31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.